Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
AstraZeneca
Jul 15, 2024, 12:19 |
Insight
Maurizio Scaltriti: Thrilled to have been invited o deliver a seminar at the Centre for Genomic Regulation
Maurizio Scaltriti, Vice President of Translational Medicine at AstraZenica, shared a post on LinkedIn: “I’m…
Jul 9, 2024, 18:09 |
Blog
Daniel Neumeier: Biopharma acquisitions H1/24
Daniel Neumeier, Life Sciences Specialist at L.E.K. Consulting, shared on LinkedIn: "Biopharma acquisitions H1/24 Number…
Jul 9, 2024, 15:37 |
Insight
10 Most Promising Cancer Drugs in 2024: What Patients Need to Know
Navigating the world of cancer treatment can be overwhelming, especially with so many new drugs…
Jul 6, 2024, 05:13 |
Insight
Tanja Obradovic: Choosing immunotherapy treatment for early resectable NSCLC
Tanja Obradovic shared on LinkedIn: "Choosing immunotherapy treatment options with PD(L)-1 inhibitors for early resectable non–small…
Jul 4, 2024, 12:43 |
Opinion
Mohit Manrao: When it comes to the world of AI, optimism drives my perspective
Mohit Manrao, SVP, Head of US Oncology at AstraZeneca, shared on LinkedIn: "When it comes…
Jul 4, 2024, 11:05 |
Blog
Christoph Varenhorst: Reflecting on a Quarter Century of Impact in Healthcare
Christoph Varenhorst, Global Vice President at AstraZeneca, shared a post on LinkedIn: . "Reflecting on…
Jul 2, 2024, 15:28 |
Blog
Sarah Louden: 2024 ASCO Direct Puerto Rico is an overwhelming success
Sarah Louden, Founder and CEO of Total Health, shared on LinkedIn: "Excellent! Stupendous! The 2024 ASCO…
Jul 2, 2024, 10:50 |
Insight
The path to leptomeningeal metastasis
Jean-Charles Soria shared a post on LinkedIn: . "Leptomeningeal metastasis occurs in 5-10% of patients…
Jul 1, 2024, 03:08 |
Blog
Stephen V Liu: Phase III Adjuvant BR.31 study does not meet primary endpoint
Stephen V Liu shared on X: “Phase III ADJUVANT BR.31 study does not meet primary…
Jun 28, 2024, 14:34 |
Blog
María Natalia Gandur Quiroga: Imfinzi Shows Significant Survival Benefits in NIAGARA Phase III Trial
María Natalia Gandur Quiroga shared on LinkedIn: . "Imfinzi Shows Significant Survival Benefits in NIAGARA…
8
9
10
11
12
All:
186
Posts:
91 - 100
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube